GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Price-to-Funds-From-Operations

LungLife AI (LSE:LLAI) Price-to-Funds-From-Operations : (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.